Company: LGN
Filing Date: 2025-04-30
Form Type: DRS/A
Source: 0000950123-25-003868
Chunk: 2

Company: Legence Corp.
Filing Date: 2025-04-30
Form: DRS/A
Chunk 2
---
US Shares Legence Corp. Class A Common Stock This is the initial public offering of the Class A common stock, par value $0.01 per share, of Legence Corp., a Delaware corporation. We are offering shares of our Class A common stock. Prior to this offering, there has been no public market for our Class A common stock. We intend to list our Class A common stock on the Nasdaq Stock Market LLC (“Nasdaq”) under the symbol “LGN.” The initial public offering price per share of the Class A common stock is estimated to be between $ and $ . We will have two classes of common stock outstanding after this offering: Class A common stock and Class B common stock, par value $0.01 per share. Holders of shares of our Class A common stock and Class B common stock are entitled to one vote for each share of Class A common stock and Class B common stock, respectively, held of record on all matters on which stockholders are entitled to vote generally. See “Description of Capital Stock.” Upon consummation of this offering and the application of proceeds therefrom, our principal asset will consist of our ownership of LGN Units (as defined below), which we will acquire from Legence Holdings (as defined below) with the net proceeds from this offering, collectively representing an aggregate % economic interest in Legence Holdings. The remaining % economic interest in Legence Holdings will be owned by the Existing Owners (as defined below) through their ownership of LGN Units. After the completion of this offering, a group of investment funds managed by Blackstone Inc. will beneficially own approximately % of the combined voting power of our Class A common stock and Class B common stock. As a result, we will be a “controlled company” within the meaning of the Nasdaq rules. See “Management—Status as a Controlled Company.” Investing in our Class A Common Stock involves risks, including those described under “ Risk Factors” beginning on page 21 of this prospectus.

|                                  |     | Per share |     | Total |
|:---------------------------------|:----|:----------|:----|:------|
| Price to the public              |     | $         |     | $     |
| Underwriting discounts and       
 commissions(1)                   |     | $         |     | $     |
| Proceeds to us (before expenses) |     | $         |     | $     |

| (1) | We refer you to “Underwriting” beginning on page 158 of